Below are the most recent articles and abstracts from Dr. Richard Chaisson and Johns Hopkins colleagues.

How research can help control tuberculosis
Chaisson RE, Johns Hopkins University Center for Tuberculosis Research, Baltimore, Maryland.
Harrington M., Treatment Action Group, New York.

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE.

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection.
David W Dowdy & Richard E Chaisson
Center for Tuberculosis Research, Johns Hopkins University
Bull World Health Organ 2009; Feb 10

FOR SUPPLEMENT MATERIALS ON THIS PAPER, CLICK HERE.

Tuberculosis incidence among contacts of active pulmonary tuberculosis.
Cailleaux-Cezar M, de A Melo D, Xavier GM, de Salles CL, de Mello FC, Ruffino-Netto A, Golub JE, Efron A, Chaisson RE, Conde MB.
Int J Tuberc Lung Dis. 2009 Feb 13

Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health.
Deluca A, Chaisson RE, Martinson NA.
J Acquir Immune Defic Syndr. 2009 Feb 1

Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.
Dowdy DW, Lourenco MC, Cavalcante SC, Saraceni V, King B, Golub JE, Bishai D, Durovni B, Chaisson RE, Dorman SE.
PLoS ONE. 2008 Dec 29.

Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
Dooley K, Flexner C, Hackman J, Peloquin CA, Nuermberger E, Chaisson RE, Dorman SE.
Antimicrob Agents Chemother. 2008 Nov 11